JP2007531510A5 - - Google Patents

Download PDF

Info

Publication number
JP2007531510A5
JP2007531510A5 JP2006536535A JP2006536535A JP2007531510A5 JP 2007531510 A5 JP2007531510 A5 JP 2007531510A5 JP 2006536535 A JP2006536535 A JP 2006536535A JP 2006536535 A JP2006536535 A JP 2006536535A JP 2007531510 A5 JP2007531510 A5 JP 2007531510A5
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
group
composition according
vertebrate
immunomer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2006536535A
Other languages
English (en)
Other versions
JP2007531510A (ja
Filing date
Publication date
Priority claimed from US10/361,111 external-priority patent/US7354907B2/en
Application filed filed Critical
Publication of JP2007531510A publication Critical patent/JP2007531510A/ja
Publication of JP2007531510A5 publication Critical patent/JP2007531510A5/ja
Pending legal-status Critical Current

Links

Claims (9)

  1. イムノマーであって、一緒に結合している2つまたは3つ以上のオリゴヌクレオチド分枝を含み、そして、構造:
    5’−NnpYpRpNnp3’−Lm−3’NnpRpYpNn−5’;式中、各Nは、独立してヌクレオシド、ヌクレオシド類似体;アラビノヌクレオシドまたは脱塩基糖から選択され;各pは、独立して天然または修飾インターヌクレオシド連鎖であり;少なくとも1つのYは、シトシン、5−ヒドロキシシトシン、N4−アルキルシトシン、4−チオウラシルまたは他の非天然ピリミジンヌクレオシド、あるいは2−オキソ−7−デアザ−8−メチル−プリンからなる群から選択され、ここで前記塩基が2−オキソ−7−デアザ−8−メチル−プリンである場合には、これは前記塩基の1位を介してペントースの1’位に共有結合しており;少なくとも1つのRは、グアニン、2−アミノ−6−オキソ−7−デアザプリン、2−アミノ−6−チオプリン、6−オキソプリンまたは他の非天然プリンヌクレオシドからなる群から選択され;Lは非ヌクレオチドリンカーであり;各nは、独立して0〜4の数値であり、但し、いずれの分枝も6ヌクレオチドを超えることはなく;mは0〜10の数値であり、そして各Nは、任意にかつ独立に、非ヌクレオチドリンカーと共有結合していてもよい、
    を有する、前記イムノマー。
  2. 請求項1に記載のイムノマーを含む、脊椎動物において免疫反応を調節するための医薬組成物
  3. 脊椎動物が、魚類、鳥類および哺乳動物からなる群から選択される、請求項2に記載の医薬組成物
  4. 哺乳動物が、ラット、マウス、ネコ、イヌ、ウマ、ウシ、ブタ、ウサギ、非ヒト霊長類およびヒトからなる群から選択される、請求項3に記載の医薬組成物
  5. 請求項1に記載のイムノマーを含む、疾患を有する脊椎動物を処置するための医薬組成物
  6. 脊椎動物が、魚類、鳥類および哺乳動物からなる群から選択される、請求項5に記載の医薬組成物
  7. 哺乳動物が、ラット、マウス、ネコ、イヌ、ウマ、ウシ、ブタ、ウサギ、非ヒト霊長類およびヒトからなる群から選択される、請求項6に記載の医薬組成物
  8. 処置されるべき疾患が、癌、自己免疫疾患、気道炎症、喘息、アレルギーおよび病原体により惹起される疾患からなる群から選択される、請求項5に記載の医薬組成物
  9. ワクチン、アレルゲン、抗原、抗体、モノクローナル抗体、化学療法剤、抗生剤、脂質、DNAワクチン、およびミョウバンなどの他のアジュバントからなる群から選択される剤をさらに含む、請求項5に記載の医薬組成物
JP2006536535A 2003-02-07 2004-01-13 短い免疫調節性オリゴヌクレオチド Pending JP2007531510A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10/361,111 US7354907B2 (en) 2003-02-07 2003-02-07 Short immunomodulatory oligonucleotides
PCT/US2004/000789 WO2004071468A2 (en) 2003-02-07 2004-01-13 Short immunomodulatory oligonucleotides

Publications (2)

Publication Number Publication Date
JP2007531510A JP2007531510A (ja) 2007-11-08
JP2007531510A5 true JP2007531510A5 (ja) 2007-12-20

Family

ID=32824138

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2006536535A Pending JP2007531510A (ja) 2003-02-07 2004-01-13 短い免疫調節性オリゴヌクレオチド

Country Status (8)

Country Link
US (2) US7354907B2 (ja)
EP (1) EP1594432A4 (ja)
JP (1) JP2007531510A (ja)
KR (1) KR20050098302A (ja)
AU (1) AU2004210625A1 (ja)
CA (1) CA2512934A1 (ja)
MX (1) MXPA05008360A (ja)
WO (1) WO2004071468A2 (ja)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100334228C (zh) * 2001-06-21 2007-08-29 戴纳瓦克斯技术公司 嵌合免疫调制化合物及其使用方法
US7785610B2 (en) * 2001-06-21 2010-08-31 Dynavax Technologies Corporation Chimeric immunomodulatory compounds and methods of using the same—III
US7276489B2 (en) * 2002-10-24 2007-10-02 Idera Pharmaceuticals, Inc. Modulation of immunostimulatory properties of oligonucleotide-based compounds by optimal presentation of 5′ ends
US7851453B2 (en) * 2003-01-16 2010-12-14 Idera Pharmaceuticals, Inc. Modulation of immunostimulatory properties of oligonucleotide-based compounds by utilizing modified immunostimulatory dinucleotides
US7354907B2 (en) * 2003-02-07 2008-04-08 Idera Pharmaceuticals, Inc. Short immunomodulatory oligonucleotides
DE10328813B4 (de) * 2003-06-20 2006-04-13 Epigenomics Ag Verfahren zur Untersuchung von Cytosin-Methylierungen in DNA-Sequenzen mittels triplexbildender Oligomere
BRPI0512110A (pt) * 2004-06-15 2007-10-23 Idera Pharmaceutical Inc multìmeros de oligonucleotìdeos imunoestimulatórios
US7498425B2 (en) * 2004-06-15 2009-03-03 Idera Pharmaceuticals, Inc. Immunostimulatory oligonucleotide multimers
US7470674B2 (en) * 2005-11-07 2008-12-30 Idera Pharmaceuticals, Inc. Immunostimulatory properties of oligonucleotide-based compounds comprising modified immunostimulatory dinucleotides
WO2011028550A1 (en) * 2009-08-24 2011-03-10 Merck Sharp & Dohme Corp. Segmented micro rna mimetics
EP2943251B1 (en) * 2013-01-08 2018-10-10 Idera Pharmaceuticals, Inc. Immune regulatory oligonucleotide (iro) compounds to modulate toll-like receptor based immune response
CA2919268C (en) 2013-07-25 2023-09-05 Exicure, Inc. Spherical nucleic acid-based constructs as immunostimulatory agents for prophylactic and therapeutic use
EP3508198A1 (en) 2014-06-04 2019-07-10 Exicure, Inc. Multivalent delivery of immune modulators by liposomal spherical nucleic acids for prophylactic or therapeutic applications
CA2968531A1 (en) 2014-11-21 2016-05-26 Northwestern University The sequence-specific cellular uptake of spherical nucleic acid nanoparticle conjugates
US11364304B2 (en) 2016-08-25 2022-06-21 Northwestern University Crosslinked micellar spherical nucleic acids
CN106754739A (zh) * 2016-12-30 2017-05-31 天津三箭生物技术股份有限公司 小鼠抗人p53单克隆抗体及分泌该单克隆抗体的杂交瘤细胞株
US11433131B2 (en) 2017-05-11 2022-09-06 Northwestern University Adoptive cell therapy using spherical nucleic acids (SNAs)
CN108178698A (zh) * 2018-03-19 2018-06-19 联保作物科技有限公司 含嘧啶核苷类抗菌素和磷酸氢二钾的复配组合物、农业杀菌剂及其应用
EP3950698A4 (en) * 2019-03-28 2023-01-25 Ajinomoto Co., Inc. METHOD FOR PRODUCING AN OLIGONUCLEOTIDE HAVING A PHOSPHOROTHIOATE SITE

Family Cites Families (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5149797A (en) * 1990-02-15 1992-09-22 The Worcester Foundation For Experimental Biology Method of site-specific alteration of rna and production of encoded polypeptides
US6346614B1 (en) * 1992-07-23 2002-02-12 Hybridon, Inc. Hybrid oligonucleotide phosphorothioates
US6207646B1 (en) * 1994-07-15 2001-03-27 University Of Iowa Research Foundation Immunostimulatory nucleic acid molecules
US5968909A (en) * 1995-08-04 1999-10-19 Hybridon, Inc. Method of modulating gene expression with reduced immunostimulatory response
US5856462A (en) * 1996-09-10 1999-01-05 Hybridon Incorporated Oligonucleotides having modified CpG dinucleosides
US6426334B1 (en) * 1997-04-30 2002-07-30 Hybridon, Inc. Oligonucleotide mediated specific cytokine induction and reduction of tumor growth in a mammal
KR100651294B1 (ko) * 1999-08-13 2006-11-28 이데라 파마슈티칼즈, 인코포레이티드 누클레오시드의 위치적 변형에 의한 올리고누클레오티드CpG-매개된 면역 자극의 조절
EP1252307B1 (en) * 2000-01-26 2008-01-02 Idera Pharmaceuticals, Inc. MODULATION OF OLIGONUCLEOTIDE CpG-MEDIATED IMMUNE STIMULATION BY POSITIONAL MODIFICATION OF NUCLEOSIDES
KR100875003B1 (ko) * 2000-05-01 2008-12-19 이데라 파마슈티칼즈, 인코포레이티드 누클레오시드의 위치 변형에 의한 올리고누클레오티드 CpG 매개성 면역 자극의 조절
WO2002008265A2 (en) * 2000-07-19 2002-01-31 Pharmacia & Upjohn Company Staphylococcus aureus ribosomal protein s20, corresponding gene and methods for the identification of antibacterial substances
KR100865706B1 (ko) * 2000-09-26 2008-10-28 이데라 파마슈티칼즈, 인코포레이티드 화학적인 위치 변화에 의해 면역자극 올리고누클레오티드유사체의 면역자극 활성을 조절하는 방법
US7176296B2 (en) * 2001-04-30 2007-02-13 Idera Pharmaceuticals, Inc. Modulation of oligonucleotide CpG-mediated immune stimulation by positional modification of nucleosides
US7105495B2 (en) * 2001-04-30 2006-09-12 Idera Pharmaceuticals, Inc. Modulation of oligonucleotide CpG-mediated immune stimulation by positional modification of nucleosides
US20030129605A1 (en) * 2001-05-04 2003-07-10 Dong Yu Immunostimulatory activity of CpG oligonucleotides containing non-ionic methylphosophonate linkages
CN100334228C (zh) * 2001-06-21 2007-08-29 戴纳瓦克斯技术公司 嵌合免疫调制化合物及其使用方法
WO2003035836A2 (en) * 2001-10-24 2003-05-01 Hybridon Inc. Modulation of immunostimulatory properties of oligonucleotide-based compounds by optimal presentation of 5' ends
US7276489B2 (en) * 2002-10-24 2007-10-02 Idera Pharmaceuticals, Inc. Modulation of immunostimulatory properties of oligonucleotide-based compounds by optimal presentation of 5′ ends
US7807803B2 (en) * 2002-07-03 2010-10-05 Coley Pharmaceutical Group, Inc. Nucleic acid compositions for stimulating immune responses
EP1393745A1 (en) * 2002-07-29 2004-03-03 Hybridon, Inc. Modulation of immunostimulatory properties of oligonucleotide-based compounds by optimal presentation of 5'ends
US7851453B2 (en) * 2003-01-16 2010-12-14 Idera Pharmaceuticals, Inc. Modulation of immunostimulatory properties of oligonucleotide-based compounds by utilizing modified immunostimulatory dinucleotides
US7354907B2 (en) * 2003-02-07 2008-04-08 Idera Pharmaceuticals, Inc. Short immunomodulatory oligonucleotides
US7569554B2 (en) * 2003-05-16 2009-08-04 Idera Pharmaceuticals, Inc. Synergistic treatment of cancer using immunomers in conjunction with therapeutic agents
EP2371834B1 (en) * 2003-06-11 2016-02-17 Idera Pharmaceuticals, Inc. Stabilized immunomodulatory oligonucleotides
AU2004259204B2 (en) * 2003-07-15 2010-08-19 Idera Pharmaceuticals, Inc. Synergistic stimulation of the immune system using immunostimulatory oligonucleotides and/or immunomer compounds in conjunction with cytokines and/or chemotherapeutic agents or radiation therapy
CA2536139A1 (en) * 2003-09-25 2005-04-07 Coley Pharmaceutical Group, Inc. Nucleic acid-lipophilic conjugates
EP2060269A3 (en) * 2003-12-08 2009-08-19 Hybridon, Inc. Modulation of immunostimulatory properties by small oligonucleotide-based compounds
AU2005216075B2 (en) * 2004-02-20 2011-03-10 Idera Pharmaceuticals, Inc. Potent mucosal immune response induced by modified immunomodulatory oligonucleotides
US7498425B2 (en) * 2004-06-15 2009-03-03 Idera Pharmaceuticals, Inc. Immunostimulatory oligonucleotide multimers
BRPI0512110A (pt) * 2004-06-15 2007-10-23 Idera Pharmaceutical Inc multìmeros de oligonucleotìdeos imunoestimulatórios
WO2006011160A1 (en) * 2004-06-28 2006-02-02 Alembic Limited Process for the preparation of azithromycin monohydrate isopropanol clathrate
EP1734583A1 (en) * 2005-06-14 2006-12-20 Photonis-DEP B.V. Electron bombarded image sensor array device and its manufactoring method
US20070093439A1 (en) * 2005-10-25 2007-04-26 Idera Pharmaceuticals, Inc. Short immunomodulatory oligonucleotides
CA2630118A1 (en) * 2005-11-07 2007-05-18 Sudhir Agrawal Immunostimulatory properties of oligonucleotide-based compounds comprising modified immunostimulatory dinucleotides
US7776834B2 (en) * 2005-11-07 2010-08-17 Idera Pharmaceuticals, Inc. Immunostimulatory properties of oligonucleotide-based compounds comprising modified immunostimulatory dinucleotides
US7470674B2 (en) * 2005-11-07 2008-12-30 Idera Pharmaceuticals, Inc. Immunostimulatory properties of oligonucleotide-based compounds comprising modified immunostimulatory dinucleotides
JP2009520502A (ja) * 2005-12-20 2009-05-28 イデラ ファーマシューティカルズ インコーポレイテッド Cgジヌクレオチド修飾物を含有するトール様受容体の新規な合成アゴニスト
WO2007075626A2 (en) * 2005-12-20 2007-07-05 Idera Pharmaceuticals, Inc. Immunostimulatory activity of palindromic immune modulatory oligonucleotides (imo tm) contiaining different lengths of palindromic segments
MX2009003398A (es) * 2006-09-27 2009-08-12 Coley Pharm Gmbh Analogos de oligonucleotidos cpg que contienen analogos t hidrofobos con actividad inmunoestimuladora mejorada.
CN101610671A (zh) * 2006-12-12 2009-12-23 艾德拉药物股份有限公司 合成的tlr9激动剂
CN101878311A (zh) * 2007-08-01 2010-11-03 艾德拉药物股份有限公司 Tlr9的新型合成性激动剂

Similar Documents

Publication Publication Date Title
JP2007531510A5 (ja)
Meurens et al. The pig: a model for human infectious diseases
Hansson et al. Effect of local anaesthesia and/or analgesia on pain responses induced by piglet castration
JP2009544279A5 (ja)
UA103298C2 (ru) Способ лечения молодых свиней с помощью антигена pcv2
EA200601603A1 (ru) Миметические антитела glp-1 человека, композиции, способы и применения
Wang et al. Morphology and chronology of diphyodont dentition in miniature pigs, Sus Scrofa
JP2012505837A5 (ja)
JP2009537507A5 (ja)
Cronin et al. The effects of farrowing nest size and width on sow and piglet behaviour and piglet survival
JP2009538344A5 (ja)
CN104885956A (zh) 母猪定位栏
Bechert et al. Fertility control options for management of free-roaming horse populations
JP2005527226A5 (ja)
TWI235666B (en) Immunogenic LHRH compositions
Blackshaw Prostaglandin F2a induced nest building behavior in the non-pregnant sow, and some welfare considerations
Banga et al. Cow urine and immunomodulation: An update on cowpathy
Jewgenow Immune contraception in wildlife animals
Pagan et al. Husbandry and breeding of Somali wild ass Equus africanus somalicus at Basel Zoo, Switzerland 1
Johnson et al. Mandibular osteosarcoma in a nutria (Myocastor coypus)
JP4629964B2 (ja) ウシの消化器疾患治療剤
Schmitt et al. Alternatives to the Use of Nonhuman Primates in Regulatory Toxicology
Gulbrandsen et al. The influence of housing system on voluntary activity of horses.
Mokopasetso Modeling foot and mouth disease risk factors in Botswana
RU2093177C1 (ru) Препарат "дина" для лечения и профилактики заболеваний млекопитающих, птиц и рептилий